Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 60.89% institutional investors, 0.05% insiders, and 39.07% retail investors. Bvf inc/il is the largest institutional shareholder, holding 20.98% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.07% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	60.89%	0.05%	39.07%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Biotech Stocks	44.91%	7.98%	47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	20.98%	$16.61M
Armistice capital	2.34M	7.79%	$6.17M
Zimmer partners, lp	2.11M	7.03%	$5.57M
Schonfeld strategic advisors	1.50M	5.00%	$3.96M
Sphera funds management	1.30M	4.32%	$3.42M
Vanguard group	1.10M	3.68%	$2.92M
Woodline partners lp	675.24K	2.25%	$1.78M
Nantahala capital management	600.00K	2.00%	$1.58M
Alyeska investment group	500.00K	1.67%	$1.32M
Ensign peak advisors	443.00K	1.48%	$1.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sphera funds management	1.30M	0.47%	$3.42M
Bvf inc/il	6.29M	0.47%	$16.61M
Cm management	160.00K	0.39%	$422.40K
Zimmer partners, lp	2.11M	0.10%	$5.57M
Nantahala capital management	600.00K	0.09%	$1.58M
Armistice capital	2.34M	0.08%	$6.17M
Jmac enterprises	58.04K	0.03%	$153.23K
Schonfeld strategic advisors	1.50M	0.03%	$3.96M
Woodline partners lp	675.24K	0.02%	$1.78M
Alyeska investment group	500.00K	0.01%	$1.32M

Top Buyers

Holder	Shares	% Assets	Change
Zimmer partners, lp	2.11M	0.10%	2.11M
Bvf inc/il	6.29M	0.47%	1.97M
Schonfeld strategic advisors	1.50M	0.03%	1.45M
Sphera funds management	1.30M	0.47%	1.30M
Nantahala capital management	600.00K	0.09%	600.00K

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	21.79K	-	-77.99K
Millennium management	-	-	-13.88K
Citadel advisors	-	-	-1.40K
Wells fargo & company/mn	-	-	-189.00
Group one trading	-	-	-22.00

New Positions

Holder	Shares	% Assets	Change	Value
Zimmer partners, lp	2.11M	0.10%	2.11M	$5.57M
Sphera funds management	1.30M	0.47%	1.30M	$3.42M
Nantahala capital management	600.00K	0.09%	600.00K	$1.58M
Alyeska investment group	500.00K	0.01%	500.00K	$1.32M
Bridgeway capital management	33.40K	0.00%	33.40K	$88.18K

Sold Out

Holder	Change
Group one trading	-22.00
Wells fargo & company/mn	-189.00
Citadel advisors	-1.40K
Millennium management	-13.88K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	31	3.33%	18,259,810	90.30%	60	3.88%	21	90.91%	1	-85.71%
Mar 31, 2024	30	3.45%	9,595,061	4.83%	39	4.25%	11	-8.33%	7	16.67%
Dec 31, 2023	29	3.57%	9,153,168	2.64%	30	2.21%	12	9.09%	6	-33.33%
Sep 30, 2023	28	-15.15%	8,917,867	-3.86%	37	0.88%	11	-31.25%	9	80.00%
Jun 30, 2023	33	6.45%	9,275,490	48.63%	64	3.40%	16	60.00%	5	25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.83M	3.07%	680.80K
Vanguard Institutional Extnd Mkt Idx Tr	385.14K	0.93%	-
Fidelity Extended Market Index	225.37K	0.54%	-143.00
BlackRock Extended Equity Market K	79.41K	0.20%	-34.00
iShares Micro-Cap ETF	87.89K	0.15%	-
NT Ext Equity Mkt Idx Fd - NL	49.18K	0.12%	-
Fidelity Total Market Index	49.74K	0.12%	5.43K
Fidelity Series Total Market Index	42.76K	0.10%	4.14K
NT Ext Equity Mkt Idx Fd - L	40.19K	0.10%	-
Northern Trust Extended Eq Market Idx	40.19K	0.10%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-
2023 Q2	9	-
2023 Q1	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 60.89%, followed by 0.05% insiders and 39.06% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 44.91%, which Eledon Pharmaceuticals exceeds.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 20.98%), Armistice capital (2.34M shares, 7.79%), and Zimmer partners, lp (2.11M shares, 7.03%). Together, they hold 35.81% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sphera funds management is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 1.3M Eledon Pharmaceuticals shares, valued at 3.42M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.07% of its total shares outstanding invested in 1.83M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools